Close Menu

NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx announced on Thursday that it has received CE-IVD marking for a qPCR assay to detect both Neisseria gonorrhoeae and sequences in the gyrA gene of the bacteria linked to ciprofloxacin susceptibility.

According to SpeeDx, the Resistance GC assay will allow doctors to confidently and cost-effectively treat up to 70 percent of gonorrhea infections with a single oral dose of ciprofloxacin.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.